Acadian Asset Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-37,873
Closed -$77K 1831
2023
Q4
$77K Buy
+37,873
New +$69.1K ﹤0.01% 1401
2022
Q1
Sell
-447,611
Closed -$5.75M 1849
2021
Q4
$5.75M Sell
447,611
-156,869
-26% -$1.74M 0.02% 428
2021
Q3
$6.53M Buy
604,480
+80,953
+15% +$737K 0.02% 397
2021
Q2
$4.78M Buy
+523,527
New +$4.84M 0.02% 478

Other funds holding GRTS

Acadian Asset Management's GRTS Position: Q1 2024 in Review

Acadian Asset Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2024, closing a stake of 37,873 shares — an estimated $77K sold.

Acadian Asset Management first reported a position in GRTS in Q2 2021 and held it in 4 quarters. The position peaked at $6.53M in Q3 2021. 85 funds tracked by Wall St. Rank hold GRTS as of Q1 2024.

  • Acadian Asset Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Acadian Asset Management sold 37,873 Gritstone bio, Inc. Common Stock shares in Q1 2024, an estimated $77K.
  • Acadian Asset Management first reported a position in Gritstone bio, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Acadian Asset Management's Gritstone bio, Inc. Common Stock position peaked at $6.53M in Q3 2021.
  • 85 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2024.

Based on Acadian Asset Management's 13F filing for Q1 2024, filed 10 May 2024.